Company
Simmunome
Your no-code, high-fidelity SaaS platform for AI-driven disease simulations.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Montreal, Canada
- Customers
- companies
- simmunome.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 19 September 2026
About
Simmunome is a TechBio company with you at every stage of drug development to make key go/no-go decisions, with confidence.
Funding snapshot
- Latest round
- Undisclosed2025-06-30
Funding rounds
- Round, 2025
- 2025-06-30
- Pre seed
- 2023-09-18
- Round, 2023
- 2023-03-09
Products
- Web
- BioTarget Scoring Tool
- Web
- Data Exploration Tool
- Web
- Omic Signatures
Loading relationship preview